HealthTech Invest

The HealthTech Invest podcast will help you be in the know on all things Healthcare Investing. Through interviews with cutting-edge health entrepreneurs, savvy investors, health system leaders, and more, the HealthTech Invest podcast powered by Niterra, will help you level up and make an impact in healthcare investing.

HealthTech Invest is a health podcast hosted by Tom Kluz, with 27 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Tom Kluz hosts HealthTech Invest, a health show with 27 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  HealthTech Invest

  The Spreadsheet Trap: Why Growth Equity Fails Without Operator Rigor with Joe Kaiser, CEO and Managing Director at Mercato Partners

  Feb 19, 202641 minS0

  Real growth investing creates durable outcomes when disciplined capital allocation is matched with operator-level rigor and clear value creation. In this episode, Joe Kaiser, CEO and Managing Director at Mercato Partners, shares how his experience at Blackstone and in operating roles, including scaling Vivint Solar from zero to $200M in revenue through an IPO and a $5B exit, shaped his “show me” mindset, quantitative rigor, and focus on unit economics. He explains Mercato’s heartland thesis, how geography affects founder incentives, talent development, and board dynamics, and what coastal investors often misunderstand about scaling outside major hubs. Joe outlines Mercato’s “head...

  ListenShow Notes
• 

  HealthTech Invest

  How AI Can Earn Trust Without Becoming A Black Box with Ken Fine, CEO of Affinity

  Feb 3, 202649 minS0

  Strong decision-making systems are built when data quality, human behavior, and trust are treated as inseparable. In this episode, Ken Fine, CEO of Affinity, shares how his career path from naval engineering and physics to enterprise SaaS leadership shaped his thinking about data, systems, and decision-making. He reflects on designing high-stakes systems in the Navy, applying behavioral economics at Financial Engines, and learning how to separate signal from noise at Medallia. Ken explains why differentiated data matters more than algorithms alone, how speed and accuracy work together to build trust, and why transparency is essential as AI becomes more embedded...

  ListenShow Notes
• 

  HealthTech Invest

  Electricity as Medicine: Inside the Future of Personalized Tremor Therapy with Deanna Harshbarger, CEO of Cala Health

  Dec 4, 202559 minS0

  What if treating tremor meant personalizing therapy to your exact physiology, every single day? In this episode, Deanna Harshbarger, CEO of Cala Health, discusses how precision neuromodulation is transforming care by measuring each patient’s unique tremor and tailoring therapy in real-time. She explains why millions of essential tremor and Parkinson’s patients are left undertreated under today’s pharma-first, procedure-heavy system. She shares how Cala’s wearable, watch-like device restores daily function and dignity without habituation or invasive surgery. She also explains why modernizing reimbursement, regulation, and clinical workflows is crucial for digital therapeutics to scale. Tune in to discover...

  ListenShow Notes
• 

  HealthTech Invest

  From Lab to Lunch: How AI Is Reimagining Nutrition and Health with Dr. Ilias Tagkopoulos, chairman and founder of PIPA

  Nov 27, 20251h 5mS0

  What if the future of health starts not in a pharmacy, but in the food we eat? In this episode, Dr. Ilias Tagkopoulos, chairman and founder of PIPA, professor at UC Davis, and director at the USDA AI Institute, talks about how academia shaped his pursuit of long-term, high-impact innovation and how that led him to build AI platforms reshaping food, nutrition, and health. He shares a personal story that shifted his company's focus from broad AI applications to the power of diet and lifestyle. He explains how AI-as-a-service has evolved, why global talent has been crucial to scaling, and...

  ListenShow Notes
• 

  HealthTech Invest

  The Untapped Potential Of AI To Tackle Complex Medical Problems with Viwat Visuthikraisee, Co-Founder and COO of Auransa

  Sep 11, 202551 minS0

  The most valuable breakthroughs in drug development come from finding the right direction before picking up speed. In this episode, Viwat Visuthikraisee, Co-Founder and COO of Auransa, discusses his journey from studying theoretical physics in Japan to building an AI-driven biotech company in the Bay Area. His early fascination with computers led to a career in software and, ultimately, to applying computational power to biopharma using human-derived molecular data to identify promising drug candidates early. He reflects on the role of large language models like ChatGPT as productivity tools that expand human capabilities without immediately replacing core programming skills. Viwat...

  ListenShow Notes

Recent guests on HealthTech Invest. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.